Luke JJ, Ascierto PA, Khattak MA, de la Cruz Merino L, et al. Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. J Clin Oncol 2024 Mar 7:JCO2302355. doi: 10.1200/JCO.23.02355.
PMID: 38452313